Dual‐functional Injectable Hydrogel for Osteoarthritis Treatments
Lei Lei,Rui Cong,Yifei Ni,Xin Cui,Xulei Wang,Hongmei Ren,Zun Wang,Mengyuan Liu,Jiasheng Tu,Lei Jiang
DOI: https://doi.org/10.1002/adhm.202302551
IF: 10
2023-11-21
Advanced Healthcare Materials
Abstract:Abstract Osteoarthritis is a prevalent, chronic degenerative disease that affects people worldwide. It is characterized by the destruction of cartilage and inflammatory reactions. High levels of ROS cause oxidative stress, which damages lipids, proteins, and DNA, leading to cell damage and death. Furthermore, ROS also induces the production of inflammatory cytokines and cell chemotaxis, further worsening the inflammatory response and damaging cartilage resulted in limited movement. Herein, we report a dual‐functional injectable hydrogel, which can help inhibit inflammation by scavenging ROS and provide lubrication to reduce wear and tear on the joints. To create the hydrogel, 3‐aminophenylboronic acid modified hyaluronic acid was synthesized, then which was crosslinked with hydroxyl‐containing PVA to construct a dual dynamic covalent crosslinked hydrogel Gel (HPP). The hydrogel mentioned here possesses a unique bond structure that allows it to be injected, self‐heal, and provide lubrication. This innovative approach offers a new possibility for treating osteoarthritis by combining anti‐inflammatory and lubrication effects. This article is protected by copyright. All rights reserved
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials